Precision Biosciences Inc

Ownership Transactions Reported by 19 Insiders

Symbol
DTIL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
302 East Pettigrew Street, Suite A 100, Durham, NC

Insiders trading volume in the past year

Precision Biosciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Novartis Pharma Ag 10%+ Owner $4.59M Jun 15, 2022
Derek Jantz Chief Scientific Officer, Director $1.51M Jun 7, 2022
J. Jefferson Smith Chief Research Officer $1.48M -$12.5K -0.84% Aug 22, 2024
R. Matthew Kane President and CEO, Director $749K Jun 7, 2021
Michael Amoroso President and CEO, Director $345K -$89.9K -20.7% Nov 2, 2024
John Alexander Kelly Chief Financial Officer $317K Nov 2, 2024
Kevin Buehler Director $163K Jun 4, 2024
Stanley Frankel Director $162K Jun 4, 2024
Shari Lisa Pire Director $161K Jun 4, 2024
Melinda Brown Director $161K Jun 4, 2024
Samuel C. Wadsworth Director $161K Jun 4, 2024
Geno J. Germano Director $161K Jun 4, 2024
Dario Scimeca General Counsel and Secretary $80.3K -$16.4K -16.9% Nov 2, 2024
Alan List Chief Medical Officer $56.4K -$13.1K -18.9% May 1, 2024
David S. Thomson Chief Operating Officer $41.3K Jun 23, 2021
Shane Barton VP & Corporate Controller $12.4K Jun 7, 2023
Fayaz Khazi CEO of Elo Life Systems $8.88K Jun 7, 2021
Shalini Sharp Director May 10, 2021
Raymond F. Schinazi Director May 10, 2022

Recent Insider Transactions by Companies or Individuals for Precision Biosciences Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.